Concepedia

1083MO Final results from ILLUMINATE-204, a phase I/II trial of intratumoral tilsotolimod in combination with ipilimumab in PD-1 inhibitor refractory advanced melanoma

Cara Haymaker, Robert H.I. Andtbacka, Douglas B. Johnson, M. Shaheen, S. Rahimian, S. Chunduru, Nashat Gabrail, Gary C. Doolittle, Igor Puzanov, Joseph Markowitz,

Annals of Oncology · 2020 · 20 citations · 0 references

DOI

Concepts